Insider Transactions in Q1 2024 at Accelerate Diagnostics, Inc (AXDX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2024
|
David Patience Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
350
-1.32%
|
$0
$0.96 P/Share
|
|
Feb 26
2024
|
David Patience Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+3.62%
|
-
|
|
Feb 01
2024
|
Jack Phillips Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
494
-0.64%
|
$494
$1.3 P/Share
|
|
Feb 01
2024
|
Jack Phillips Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.28%
|
-
|
|
Jan 23
2024
|
John Patience Director |
BUY
Open market or private purchase
|
Indirect |
16,666
+3.55%
|
-
|
|
Jan 23
2024
|
David Patience Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,666
+39.43%
|
-
|
|
Jan 23
2024
|
Hany Massarany Director |
BUY
Open market or private purchase
|
Direct |
16,666
+40.72%
|
-
|
|
Jan 23
2024
|
Louise Francesconi Director |
BUY
Open market or private purchase
|
Direct |
13,333
+38.92%
|
-
|
|
Jan 23
2024
|
Jack Phillips Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,666
+17.95%
|
-
|
|
Jan 23
2024
|
Jack W Schuler Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,156,069
+14.26%
|
-
|
|
Jan 23
2024
|
Matthew Strobeck Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+45.31%
|
-
|